Monitor de Dolor Oncológico

Features Monitor de Dolor Oncológico

Dra.
Azucena García Palacios, a researcher at the Laboratory of Psychology and Technology, the University Jaume I of Castellón.
One of his research areas is chronic pain.This application is intended to investigate how it influences pain in the daily lives of people who suffer from cancer pain and is part of a research project conducted by the University Jaume I of Castellón with the Oncology Unit of the Provincial Hospital of Castellon .FOR 30 DAYS ask you (once in the morning and evening) a few brief questions related to pain.
It only takes 2 minutes to answer.In addition we would like to monitor how you feel when you have an episode of acute pain.
When this happens, enter the application and responds to preguntas.Todos data that you provide will serve to advance our knowledge of chronic pain and seek ways to improve the quality of life of people who suffer.Downloading this application you agree to participate in this study anonymously.If you want to participate in other research or would like to receive information on the results of this research, please write to [email protected] selection of the content of this APP has been made following the recommendations of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials, IMMPACT) and following a biopsychosocial approach to pain.
This material has been used not for profit, for research purposes and relies therefore to all intents and purposes as provided by Article 37 of the Spanish Intellectual Property Law 22/1987.The original content App Monitor Pain was created by consensus with experts in pain research group Labpsitec (Jaume I University) and Pain Unit of the Hospital Vall dHebron and its validation has been published in The Clinical Journal of Pain.
Adapting to assess breakthrough pain oncological was carried out with the support of the Provincial Hospital of Castellon, after a series of meetings with the oncology team, which was reached an agreement on which variables to add or modify to tailor content oncologic breakthrough pain.